Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Health and Healthcare

Biogen : BIIB

All Biogen Articles

607 Articles

Chris Lange | Mar 20, 2015 at 9:50 AM EDT

Alzheimer’s Drug Could Be Instant Blockbuster for Biogen Idec

Friday morning, Biogen Idec announced positive results related to its Alzheimer's study. Any real Alzheimer's drug certainly would make the…

Chris Lange | Mar 18, 2015 at 2:10 PM EDT

How the Weaker Euro Is Impacting Biotech Earnings

Wells Fargo released a report Wednesday that considers the future of major biotech companies in relation to the weak euro.

Lee Jackson | Mar 16, 2015 at 8:15 AM EDT

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech…

Chris Lange | Mar 11, 2015 at 9:15 AM EDT

Short Sellers Get More Aggressive on Big Biotech

24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with…

Jon C. Ogg | Mar 6, 2015 at 7:15 AM EST

9 Well-Established Companies That Just Refuse to Pay Dividends

24/7 Wall St. has identified nine solid companies that are on very stable ground but that just refuse to pay…

Lee Jackson | Mar 4, 2015 at 8:35 AM EST

The 5 Most Loved Biotech Stocks of Portfolio Managers

A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money…

Chris Lange | Feb 26, 2015 at 9:25 AM EST

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech…

Jon C. Ogg | Feb 23, 2015 at 2:05 PM EST

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

24/7 Wall St. wanted to find out which of the major Nasdaq stocks would lead the index back over 5,000…

Lee Jackson | Feb 18, 2015 at 8:25 AM EST

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid…

Chris Lange | Feb 11, 2015 at 9:40 AM EST

Short Sellers Look Scared of Big Biotech

The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech…

Chris Lange | Jan 30, 2015 at 10:35 AM EST

Did Biogen Run Too Much After Earnings?

Biogen Idec shares hit a new multiyear high Friday morning following the better-than-expected fourth-quarter earnings.

Chris Lange | Jan 28, 2015 at 11:00 AM EST

Short Sellers Starting to Gang Up on Biotech

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected…

Chris Lange | Jan 13, 2015 at 8:55 AM EST

Short Interest in Biotechs Signals Optimism

24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.

Chris Lange | Jan 7, 2015 at 2:51 PM EST

Wells Fargo’s Top Biotech Stocks for 2015

ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech…

Lee Jackson | Jan 7, 2015 at 10:35 AM EST

Analyst’s 8 Top Health Care Stocks for 2015

A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have…

1 … 24 25 26 27 28 … 41

Biogen : BIIB

All Biogen Articles

Alzheimer’s Drug Could Be Instant Blockbuster for Biogen Idec

How the Weaker Euro Is Impacting Biotech Earnings

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

Short Sellers Get More Aggressive on Big Biotech

9 Well-Established Companies That Just Refuse to Pay Dividends

The 5 Most Loved Biotech Stocks of Portfolio Managers

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Short Sellers Look Scared of Big Biotech

Did Biogen Run Too Much After Earnings?

Short Sellers Starting to Gang Up on Biotech

Short Interest in Biotechs Signals Optimism

Wells Fargo’s Top Biotech Stocks for 2015

Analyst’s 8 Top Health Care Stocks for 2015

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

Missed CRWD’s Rally? This ETF Paid 29% in the Same Six Months

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Biogen : BIIB

All Biogen Articles

Alzheimer’s Drug Could Be Instant Blockbuster for Biogen Idec

How the Weaker Euro Is Impacting Biotech Earnings

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

Short Sellers Get More Aggressive on Big Biotech

9 Well-Established Companies That Just Refuse to Pay Dividends

The 5 Most Loved Biotech Stocks of Portfolio Managers

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Short Sellers Look Scared of Big Biotech

Did Biogen Run Too Much After Earnings?

Short Sellers Starting to Gang Up on Biotech

Short Interest in Biotechs Signals Optimism

Wells Fargo’s Top Biotech Stocks for 2015

Analyst’s 8 Top Health Care Stocks for 2015

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

Missed CRWD’s Rally? This ETF Paid 29% in the Same Six Months

Featured Reads

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

She Claimed Social Security at 62 and Regretted It Within the Year. One Form Let Her Take It All Back